Cite
Effectiveness, safety and utilization of vismodegib in locally advanced basal cell carcinoma under real‐world conditions in Germany – The non‐interventional study NIELS.
MLA
Gutzmer, R., et al. “Effectiveness, Safety and Utilization of Vismodegib in Locally Advanced Basal Cell Carcinoma under Real‐world Conditions in Germany – The Non‐interventional Study NIELS.” Journal of the European Academy of Dermatology & Venereology, vol. 35, no. 8, Aug. 2021, pp. 1678–85. EBSCOhost, https://doi.org/10.1111/jdv.17332.
APA
Gutzmer, R., Schulze, H. ‐J., Hauschild, A., Leiter, U., Meier, F., Haferkamp, S., Ulrich, C., Wahl, R. U., Berking, C., Herbst, R., Häckl, M., & Schadendorf, D. (2021). Effectiveness, safety and utilization of vismodegib in locally advanced basal cell carcinoma under real‐world conditions in Germany – The non‐interventional study NIELS. Journal of the European Academy of Dermatology & Venereology, 35(8), 1678–1685. https://doi.org/10.1111/jdv.17332
Chicago
Gutzmer, R., H.‐J. Schulze, A. Hauschild, U. Leiter, F. Meier, S. Haferkamp, C. Ulrich, et al. 2021. “Effectiveness, Safety and Utilization of Vismodegib in Locally Advanced Basal Cell Carcinoma under Real‐world Conditions in Germany – The Non‐interventional Study NIELS.” Journal of the European Academy of Dermatology & Venereology 35 (8): 1678–85. doi:10.1111/jdv.17332.